Cargando…

Efficacy of different durations of antifungal prophylaxis with nebulized amphotericin B after lung transplantation: a retrospective cohort study

BACKGROUND: Nebulized amphotericin B (NAB) is recommended for preventing invasive fungal diseases (IFDs) after lung transplantation. However, the optimal duration of NAB treatment is still unknown. This study aimed to compare the effectiveness of three different durations of antifungal prophylaxis w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ju, Chunrong, Lian, Qiaoyan, Wang, Xiaohua, Wang, Lulin, Zhang, Jianheng, Cai, Yuhang, Xu, Xin, Chen, Rongchang, He, Jianxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636437/ https://www.ncbi.nlm.nih.gov/pubmed/37969308 http://dx.doi.org/10.21037/jtd-23-601

Ejemplares similares

Cytomegalovirus seroprevalence, infection, and disease in Chinese thoracic organ transplant recipients: a retrospective cohort study
por: Ju, Chunrong, et al.
Publicado: (2022)

Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study
por: Rombauts, Alexander, et al.
Publicado: (2023)

Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2022)

Clinical outcomes and survival following lung transplantation for work-related lung disease: a single-center retrospective cohort study
por: Ju, Chunrong, et al.
Publicado: (2023)

Epidemiology and Prognosis of Invasive Fungal Disease in Chinese Lung Transplant Recipients
por: Ju, Chunrong, et al.
Publicado: (2021)

Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2023)

Differentiation between lung allograft rejection and infection using donor-derived cell-free DNA and pathogen detection by metagenomic next-generation sequencing
por: Ju, Chunrong, et al.
Publicado: (2023)

1554. Nebulized Liposomal Amphotericin B for Treatment of Murine Pulmonary Mucormycosis
por: Sandoval, Adilene, et al.
Publicado: (2019)

Use of Nebulized Amphotericin B in the Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
por: Proesmans, M., et al.
Publicado: (2010)

Fingolimod Potentiates the Antifungal Activity of Amphotericin B
por: Wei, Lu-Qi, et al.
Publicado: (2021)

Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B()
por: Cho, Do-Yeon, et al.
Publicado: (2017)

Effect of Nebulized Amphotericin B in Critically ill Patients With Respiratory Candida spp. De-colonization: A Retrospective Analysis
por: Du, Hangxiang, et al.
Publicado: (2021)

Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
por: Faustino, Célia, et al.
Publicado: (2020)

Design of amphotericin B oral formulation for antifungal therapy
por: Liu, Min, et al.
Publicado: (2017)

Effectiveness of nebulized amphotericin B to eradicate Candida colonization from the lower respiratory tracts of ICU patients
por: Ong, DSY, et al.
Publicado: (2012)

1577. Particle Characterization of Nebulized Liposomal Amphotericin B and Its Use in the Treatment of Murine Pulmonary Aspergillosis
por: Dave, Janam J, et al.
Publicado: (2019)

Micafungin as antifungal prophylaxis in non-transplanted haemotological patients
por: Villaescusa, Teresa, et al.
Publicado: (2020)

Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021)

Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study
por: Melchers, Max, et al.
Publicado: (2022)

Inhibition of Nucleotide Biosynthesis Potentiates the Antifungal Activity of Amphotericin B
por: Banerjee, Dithi, et al.
Publicado: (2014)

Inhaled Amphotericin B as Aspergillosis Prophylaxis in Hematologic Disease: An Update
por: Duckwall, Madison J, et al.
Publicado: (2019)

Reply: Antifungal Prophylaxis
por: Pennington, Kelly M., et al.
Publicado: (2021)

Preparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres
por: Gharib, A, et al.
Publicado: (2011)

Antifungal Activity of Amphotericin B Conjugated to Nanosized Magnetite in the Treatment of Paracoccidioidomycosis
por: Saldanha, Camila Arruda, et al.
Publicado: (2016)

Branched amphotericin functional poly(N-isopropyl acrylamide): an antifungal polymer
por: Swift, Thomas, et al.
Publicado: (2021)

Nasal Gel Loaded with Amphotericin Nanotransferosomes as Antifungal Treatment for Fungal Sinusitis
por: Hosny, Khaled M., et al.
Publicado: (2020)

Lipase-Responsive Amphotericin B Loaded PCL Nanoparticles for Antifungal Therapies
por: Uroro, Evelyn Osehontue, et al.
Publicado: (2022)

Safety and Efficacy of Intermittent High-Dose Liposomal Amphotericin B Antifungal Prophylaxis in Haemato-Oncology: An Eight-Year Single-Centre Experience and Review of the Literature
por: Youngs, Jonathan, et al.
Publicado: (2020)

2737. Real World Evaluation of Antifungal Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant (aHSCT) Patients, Is Routine Antifungal Prophylaxis Needed?
por: Perreault, Sarah, et al.
Publicado: (2023)

Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
por: Akers, Kevin S, et al.
Publicado: (2015)

Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B
por: Adler-Moore, Jill, et al.
Publicado: (2019)

Antifungal Efficacy of Amphotericin B in Candida Albicans Endocarditis Therapy: Systematic Review
por: Bezerra, Lucas Soares, et al.
Publicado: (2020)

Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats
por: Radwan, Mahasen A., et al.
Publicado: (2017)

Antifungal Prophylaxis in Immunocompromised Patients
por: Vazquez, Lourdes
Publicado: (2016)

Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo
por: Tang, Xiaolong, et al.
Publicado: (2014)

Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole
por: Udawatte, Nadeeka S., et al.
Publicado: (2020)

Factors Associated with Impairment of Quadriceps Muscle Function in Chinese Patients with Chronic Obstructive Pulmonary Disease
por: Ju, Chunrong, et al.
Publicado: (2014)

Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis
por: Shirkhani, Khojasteh, et al.
Publicado: (2015)

SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
por: Lindsay, Julian, et al.
Publicado: (2021)

It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
por: Mesa-Arango, Ana C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rdunq3kstrh7obcgvlv6fk00v3